Derek M Meisner's Net Worth
$380 Thousand
Who is Derek M Meisner?
Derek M Meisner does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GENOCEA BIOSCIENCES, INC., X4 Pharmaceuticals, Inc, and Acumen Pharmaceuticals, Inc..
SEC CIK
Derek M Meisner's CIK is 0001752461
Past Insider Trading and Trends
2021 was Derek M Meisner's most active year for acquiring shares with 3 total transactions. Derek M Meisner's most active month to acquire stocks was the month of December. 2022 was Derek M Meisner's most active year for disposing of shares, totalling 4 transactions. Derek M Meisner's most active month to dispose stocks was the month of May. 2022 saw Derek M Meisner paying a total of $0.00 for 330,000 shares, this is the most they've acquired in one year. In 2020 Derek M Meisner cashed out on 8,334 shares for a total of $67,088.70, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENOCEA BIOSCIENCES, INC. No price found
SENIOR VP AND GENERAL COUNSEL
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
X4 Pharmaceuticals, Inc (XFOR) Snapshot price: $0.8554
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.43% | -8.33K |
—
|
—
| 145.16K |
Scheduled
|
Aug 17
| ||
Form 4
| -2.64% | -4.17K |
—
|
—
| 153.49K |
Scheduled
|
Jun 24
| ||
Form 4
| -2.57% | -4.17K |
—
|
—
| 157.66K |
Scheduled
|
Jun 16
| ||
Form 4
| +184.79% | 105K |
—
|
—
| 161.82K |
Mar 1
| |||
Form 4
| -21.87% | -15.91K |
—
|
—
| 56.82K |
Scheduled
|
Feb 11
| ||
Form 4
| -10.28% | -8.33K |
$5.10 | -$42,493.20 | 72.73K |
Scheduled
|
Aug 17
| ||
Form 4
| +11.46% | 8.33K |
$7.00 | -$29,162.00 | 81.06K |
Scheduled
|
Jun 23 - Jun 24
| ||
Form 4
| +12.94% | 8.33K |
$7.84 | -$32,661.44 | 72.73K |
Scheduled
|
Jun 15
| ||
Form 4
| +286.38% | 47.73K |
—
|
—
| 64.39K |
Mar 24
| |||
Form 4
| -33.34% | -8.33K |
$8.05 | -$67,088.70 | 16.67K |
Scheduled
|
Sep 9
| ||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Aug 14 - Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Acumen Pharmaceuticals, Inc. (ABOS) Snapshot price: $3.145
Chief Legal Officer & Corp Sec
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.58% | -8.93K |
$3.48 | -$31,048.43 | 108.87K |
Scheduled
|
Jan 19
| ||
Form 4
| +339.55% | 91K |
—
|
—
| 117.8K |
Jan 2
| |||
Form 4
|
∞
| 26.8K |
—
|
—
| 26.8K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||